High Incidence of Allograft Cirrhosis in Hepatitis C Virus Genotype 1b Infection Following Transplantation: Relationship With Rejection Episodes
| table 3. Factors Associated With the Development of Graft Cirrhosis in HCV-Positive Patients Following Liver Transplantation |
|
|
Patients With
Cirrhosis
(n = 12) |
Patients
Without
Cirrhosis
(n = 69) |
P |
|
| Age |
53.2 ± 10.8 |
54.7 ± 7.4 |
.53 |
| Female sex, n (%) |
6 (50) |
19 (27.5) |
.12 |
| Pre-OLT HCC, n (%) |
2 (17) |
17 (25) |
.55 |
| Duration of histologic follow-up (mo) |
30 ± 14 |
31.8 ± 17.2 |
.32 |
| Patients with rejection episodes, n (%) |
10 (83) |
33 (48) |
.02 |
| Patients treated for rejection, n (%) |
9 (75) |
29 (42) |
.03 |
| Patients receiving OKT3 for SRR, n (%) |
2 (17) |
3 (4) |
.32 |
| Patients with early rejection, n (%)* |
9 (75) |
28 (41) |
.03 |
| Patients treated for early rejection, n (%) |
8 (67) |
25 (36) |
.05 |
| Patients with late rejection, n (%)* |
5 (42) |
8 (12) |
.009 |
| Patients treated for late rejection, n (%) |
4 (33) |
8 (12) |
.05 |
| Patients with mild rejection, n (%) |
5 (42) |
19 (27) |
.32 |
| Patients with moderate rejection, n (%) |
4 (33) |
15 (22) |
.38 |
| Patients with severe rejection, n (%) |
3 (25) |
1 (1) |
.009 |
| Number of rejection episodes |
1.2 ± 0.7 |
0.5 ± 0.6 |
.001 |
| Number of MP boluses |
3 ± 2.2 |
1.5 ± 2.1 |
.03 |
|
Abbreviations: SRR, steroid-resistant rejection; MP, methylprednisolone.
* Early rejection was defined as rejection occurring within the first 4 weeks following transplantation, while late rejection refers to rejection episodes occurring after the first month. |
Return To Article
Table Of Contents
|
